Condition: Ulcerative Colitis (UC) · UC - Ulcerative Colitis · Sponsor: Odyssey Therapeutics
The purpose of this study is to evaluate the clinical efficacy and safety of OD-07656 in participants with moderately to severely active ulcerative colitis (UC). In addition, the study will evaluate the potential of OD-07656 to enhance the therapeutic benefit of vedolizumab when given after OD-07656.
This description comes directly from the study's public registry record.
Head of Clinical Operations · 857-393-6160 · clinicaltrials@odysseytx.com
Always discuss trial participation with your own doctor first.
| Sunshine Coast University | Birtinya, Australia | Recruiting |
| Eastern Health | Box Hill, Australia | Recruiting |
| Coastal Digestive Health | Maroochydore, Australia | Recruiting |
| Alfred Health | Melbourne, Australia | Recruiting |
| Fiona Stanley Hospital | Murdoch, Australia | Recruiting |
| Royal Melbourne Hospital | Parkville, Australia | Recruiting |
| Medical University of Graz | Graz, Austria | Recruiting |
| CHUM | Montreal, Canada | Recruiting |
| Montreal General Hospital/McGill University | Montreal, Canada | Recruiting |
| CHUM - Pavillon R | Polička, Czechia | Recruiting |
| Jordan University Hospital | Amman, Jordan | Recruiting |
| The Specialty Hospital (TSH) / Advanced Clinical Center | Amman, Jordan | Recruiting |
+ 20 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06850727